|Articles|September 24, 2015

Bristol-Myers Squibb to Take Part in Leerink Partners Inaugural Immuno-Oncology Roundtable Conference

Bristol-Myers Squibb will take part in Leerink Partners Immuno-Oncology Roundtable on October 1.

PRESS RELEASE

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) will take part in Leerink Partners Immuno-Oncology Roundtable on Thursday, October 1, 2015, in New York. Michael Giordano, senior vice president, Head of Development, Oncology, will answer questions about the company at 10 a.m. EDT.

Investors and the general public are invited to listen to a live webcast of the session athttp://investor.bms.com. An archived edition of the session will be available later that day.

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

Bristol-Myers Squibb to Take Part in Leerink Partners Inaugural Immuno-Oncology Roundtable Conference

Newsletter

Related Content

Expert: Epcoritamab-Based Therapy Reduces Progression Risk in Follicular Lymphoma

'High-Stakes Headaches': Why Pharmacists May be Key to Better Headache Management

FDA Grants National Priority Vouchers to Enlicitide Decanoate, Sacituzumab Tirumotecan

Surveys Find Significant Gaps in Public’s Understanding of Shared Decision-Making on Vaccinations

Megestrol Acetate’s Role in Early-Stage ER-Positive Breast Cancer

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Empowering Patients With COPD: The Pharmacist's Role in Personalized Treatment Strategies

Implementing Updated RSV Vaccination Recommendations for Older Adults: Considerations for the Pharmacist (Part 3)

Implementing Updated RSV Vaccination Recommendations for Older Adults: Introduction and Disease Burden (Part 1)

Implementing Updated RSV Vaccination Recommendations for Older Adults: Incorporating ACIP Guidelines (Part 2)

Implementing Updated RSV Vaccination Recommendations for Older Adults: Introduction and Disease Burden (Pharmacy Technician Credit)

Implementing Updated RSV Vaccination Recommendations for Older Adults: RSV Case Discussion (Pharmacy Technician Credit)

Navigating Diabetes: A Guide to Effective Oral Treatments

Advancing Acute Pain Care: Breakthrough Non-Opioid Therapies and the Pharmacist's Critical Role

Hyperlipidemia Overview and the Clinical and Economic Burden

Improving Patient Outcomes in Seasonal and Perennial Allergic Conjunctivitis

Leveraging Managed Care to Optimize Patient Outcomes: Integrating Novel Treatments in Schizophrenia

Beyond the Spots: Management of Measles

Exploring Therapeutic Advances in Myelofibrosis and Key Considerations for Effective Management

Managed Care Approaches and Models for Equitable Access to Innovations in Major Depressive Disorder Treatment

Evaluating the Effectiveness and Value of Novel Nonhormonal Treatments in the Management of Menopause-Related Vasomotor Symptoms

Navigating the Advancements in Oral Therapy Options in HR+ Metastatic Breast Cancer

Navigating the Changing Treatment Paradigm of Metabolic Dysfunction-Associated Steatohepatitis: A Guide for Managed Care Pharmacists

Tracking a Moving Target in HR+ Metastatic Breast Cancer: Innovative Oral Therapies and Evolving Strategies

An Evolving Treatment Paradigm: Innovative Approaches and Critical Insights in the Management of Newly Diagnosed Multiple Myeloma

Advancing Care in HER2-Negative Early Breast Cancer: Essential Insights and Best Practices for Oncology Pharmacists

Exploring Therapeutic Advances in Myelofibrosis and Key Considerations for Effective Management

Transforming Lymphoma Treatment With Bispecific Antibodies: Practical Solutions for Oncology Pharmacy Teams

Navigating the World of Insulin: An Update on Types, Uses, and Considerations

PBM Challenges and the Evolving Role of Oncology Pharmacists in Community Practices

Streamlining Pharmacist-Led Hyperglycemia Management in HR+ Breast Cancer: Overcoming PI3K/AKT Inhibitor Challenges

Leveraging Biologics and Immunotherapies in the Management of Food Allergies

Advancing Care in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Optimizing Outcomes With Emerging Therapies

JAK(i) of All Trades: Navigating Myelofibrosis Treatment and Safety in Community Oncology Practice

Beyond Chimeric Antigen Receptor T-Cell Therapy: Comprehensive Approaches for Community Oncology Practices in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Advancing Chronic Lymphocytic Leukemia Treatment in the Community: Practical Updates and Clinical Pearls for Oncology Pharmacists

Transforming Metabolic Dysfunction-Associated Steatohepatitis Management: Pharmacist Considerations for the Evolving Treatment Landscape

Shaping the Future of Renal Cell Carcinoma: A Case-Based Exploration of Emerging Treatment and Improved Patient Outcomes

Innovations in Inflammatory Bowel Disease Therapy: How IL-23 Inhibitors Are Shaping Treatment and Managed Care Approaches

Demystifying CGM: Addressing Frequently Asked Questions and Key Insights

A Deep Dive Into CGM Data (Pharmacy Technician Credit)

Continuous Glucose Monitoring: What's New in 2025? (Pharmacy Technician)

A Deep Dive Into CGM Data

Advances and Innovations in Hypertrophic Cardiomyopathy Management: A Focus on New and Emerging Therapies

Understanding and Personalizing Chronic Obstructive Pulmonary Disease Diagnosis and Treatment

Respiratory Syncytial Virus Disease Prevention in Adults: The Pharmacist’s Role in Improving Vaccine Uptake

Discipline Decoded: Navigating Pharmacy Law and Disciplinary Cases

Beyond the Prescription: Tackling Social Isolation for Better Health

Leveraging Novel Therapies to Transform Demodex Blepharitis Care

Advancing Multiple Sclerosis Treatment: Exploring Evolving Therapies and Patient-Centered Approaches

The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmacist Credit)

Adapting to Advances in EGFR-Positive Non-Small Cell Lung Cancer Treatment: Critical Insights for Oncology Pharmacists

VMAT2 Inhibitors for Long-Term Success in Tardive Dyskinesia

Bridging Knowledge Gaps in HR+/HER2– Early-Stage Breast Cancer

From Flares to Freedom: Navigating the Journey of Patients With Chronic Spontaneous Urticaria With Next-Generation Therapies

Shaping the Future of Generalized Myasthenia Gravis Management: A Focus on Novel Treatment Approaches

Type 2 Inflammation in Focus: Advancing Pediatric Atopic Dermatitis Care With Biologic Therapies

Chronic Obstructive Pulmonary Disease and Inflammation: Practical Approaches to Integrating Biologic Therapy

Innovations in Lymphoma Treatment and the Growing Impact of Bispecific Antibodies

Addressing the Burden of Hemolysis in Paroxysmal Nocturnal Hemoglobinuria: The Pharmacist's Contribution to Patient Care

From Treatment to Prevention: Navigating the Expanding Hereditary Angioedema Treatment Landscape

The Oncology Pharmacist's Role in Managing Small Molecule Inhibitor Use in Chronic Lymphocytic Leukemia to Enhance Patient-Centered Care

Redefining Complement-Mediated Kidney Disease: The Latest in Diagnosis and Treatment

Advancing Pharmacist Expertise in R/R FL: Navigating Novel Therapies and Optimizing Patient Outcomes

Innovations in Hidradenitis Suppurativa Treatment: Navigating the Evolving Landscape

Optimizing Outcomes in Myasthenia Gravis: Therapeutic Advances and Value-Based Care Models

Navigating Novel Therapies in Steroid-Refractory cGVHD: Practical Strategies for Community-Based Oncology Pharmacists

Reducing Transfusion Burden in Myeloid Disorders: Novel Therapeutic Strategies and Pharmacist Interventions

Optimizing Patient Outcomes in R/R DLBCL: Bridging Knowledge Gaps for Oncology Pharmacists in the Era of Novel Immunotherapies

Understanding mRNA Vaccines: Dispelling Myths and Empowering Pharmacists to Counsel Patients

Understanding mRNA Vaccines: Dispelling Myths and Empowering Pharmacists to Counsel Patients (Pharmacy Technician Credit)

Precision Matters: Foundations of Biomarker-Driven Care in Non-Small Cell Lung Cancer

From Testing to Treatment: Empowering Pharmacists to Overcome Barriers and Optimize Biomarker-Driven Care

Clinical Presentation of Hyperglycemia with PI3K and AKT Inhibitors

Optimizing Lipid Management in Statin-Intolerant Populations: Payer Strategies for Evidence-Based Access and Risk Reduction

Protecting Against Meningococcal Disease: Updates on Vaccines, Guidelines, and Pharmacist Best Practices